Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins.
Yan Y, Yang J, Xiao D, Yin J, Song M, Xu Y, Zhao L, Dai Q, Li Y, Wang C, Wang Z, Ren X, Yang X, Ni J, Liu M, Guo X, Li W, Chen X, Liu Z, Cao R, Zhong W.
Yan Y, et al. Among authors: liu z, liu m.
Antiviral Res. 2022 Jun;202:105325. doi: 10.1016/j.antiviral.2022.105325. Epub 2022 Apr 20.
Antiviral Res. 2022.
PMID: 35460703
Free article.